Agios Pharmaceuticals (AGIO) News Today $30.28 +0.18 (+0.58%) As of 10:53 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period Agios Pharmaceuticals (NASDAQ:AGIO) Announces Earnings ResultsAgios Pharmaceuticals (NASDAQ:AGIO - Get Free Report) posted its earnings results on Thursday. The biopharmaceutical company reported ($1.55) earnings per share for the quarter, topping the consensus estimate of ($1.80) by $0.25. Agios Pharmaceuticals had a net margin of 1,845.92% and a negative return on equity of 2.51%.May 5 at 9:24 AM | marketbeat.comArrowMark Colorado Holdings LLC Acquires 34,689 Shares of Agios Pharmaceuticals, Inc. (NASDAQ:AGIO)ArrowMark Colorado Holdings LLC boosted its holdings in shares of Agios Pharmaceuticals, Inc. (NASDAQ:AGIO - Free Report) by 3.9% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 917,420 shares of the biopharMay 5 at 6:47 AM | marketbeat.comPDT Partners LLC Reduces Stock Position in Agios Pharmaceuticals, Inc. (NASDAQ:AGIO)PDT Partners LLC lessened its position in shares of Agios Pharmaceuticals, Inc. (NASDAQ:AGIO - Free Report) by 85.0% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 8,485 shares of the biopharmaceutical company's stock after selling 48May 5 at 5:11 AM | marketbeat.comScotiabank Cuts Agios Pharmaceuticals (NASDAQ:AGIO) Price Target to $71.00Scotiabank cut their price objective on shares of Agios Pharmaceuticals from $74.00 to $71.00 and set a "sector outperform" rating for the company in a report on Friday.May 4 at 10:45 AM | marketbeat.comAgios Pharmaceuticals, Inc. (AGIO) Q1 2025 Earnings Call TranscriptMay 3 at 7:32 PM | seekingalpha.comLeerink Partnrs Brokers Decrease Earnings Estimates for AGIOAgios Pharmaceuticals, Inc. (NASDAQ:AGIO - Free Report) - Equities research analysts at Leerink Partnrs dropped their Q2 2025 earnings per share estimates for Agios Pharmaceuticals in a research report issued on Monday, April 28th. Leerink Partnrs analyst A. Berens now anticipates that the biophaMay 3 at 7:45 AM | marketbeat.comAgios Pharmaceuticals, Inc. (NASDAQ:AGIO) is Caligan Partners LP's 7th Largest PositionCaligan Partners LP increased its holdings in shares of Agios Pharmaceuticals, Inc. (NASDAQ:AGIO - Free Report) by 8.0% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 626,280 shares of the biopharmaceuMay 3 at 7:44 AM | marketbeat.comEquities Analysts Offer Predictions for AGIO Q2 EarningsMay 3 at 2:19 AM | americanbankingnews.comStockNews.com Upgrades Agios Pharmaceuticals (NASDAQ:AGIO) to "Hold"May 3 at 1:33 AM | americanbankingnews.comAgios pharmaceuticals outlines key catalysts for PYRUKYND pipeline in 2025May 2 at 11:35 PM | msn.comAgios Pharmaceuticals Inc (AGIO) Q1 2025 Earnings Call Highlights: Strategic Advancements Amid ...May 2 at 11:35 PM | finance.yahoo.comAgios to Present at the BofA Securities 2025 Health Care Conference on May 14, 2025May 2 at 7:00 AM | globenewswire.comAgios Pharmaceuticals, Inc. 2025 Q1 - Results - Earnings Call PresentationMay 2 at 1:42 AM | seekingalpha.comAgios Reports First Quarter 2025 Financial Results and Recent Business HighlightsMay 1, 2025 | globenewswire.com6AGIO : An Overview of Agios Pharmaceuticals's EarningsApril 30, 2025 | benzinga.com303,000 Shares in Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) Acquired by Adage Capital Partners GP L.L.C.Adage Capital Partners GP L.L.C. purchased a new stake in shares of Agios Pharmaceuticals, Inc. (NASDAQ:AGIO - Free Report) in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm purchased 303,000 shares of the biopharmaceuApril 30, 2025 | marketbeat.comAgios Pharmaceuticals, Inc. (NASDAQ:AGIO) Shares Sold by Price T Rowe Associates Inc. MDPrice T Rowe Associates Inc. MD cut its holdings in Agios Pharmaceuticals, Inc. (NASDAQ:AGIO - Free Report) by 14.4% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,423,537April 30, 2025 | marketbeat.comSickle Cell Disease Pipeline Insight 2025: Analysis of 40+ Companies and 50+ Pipeline Drugs in the Sickle Cell Disease Pipeline LandscapeApril 30, 2025 | finance.yahoo.comInvesco Ltd. Cuts Holdings in Agios Pharmaceuticals, Inc. (NASDAQ:AGIO)Invesco Ltd. cut its position in shares of Agios Pharmaceuticals, Inc. (NASDAQ:AGIO - Free Report) by 29.8% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 83,515 shares of the biopharmaceutical company's stock after selling 35,432 shApril 30, 2025 | marketbeat.comGuggenheim Capital LLC Purchases Shares of 13,703 Agios Pharmaceuticals, Inc. (NASDAQ:AGIO)Guggenheim Capital LLC acquired a new position in shares of Agios Pharmaceuticals, Inc. (NASDAQ:AGIO - Free Report) in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm acquired 13,703 shares of the biopharmaceutical compApril 29, 2025 | marketbeat.comBarclays PLC Sells 90,864 Shares of Agios Pharmaceuticals, Inc. (NASDAQ:AGIO)Barclays PLC lowered its stake in Agios Pharmaceuticals, Inc. (NASDAQ:AGIO - Free Report) by 42.7% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 121,753 shares of the biopharmaceutical company's stock after selling 90,864 sharesApril 29, 2025 | marketbeat.comAgios Pharmaceuticals, Inc. (NASDAQ:AGIO) Shares Bought by Boothbay Fund Management LLCBoothbay Fund Management LLC lifted its stake in shares of Agios Pharmaceuticals, Inc. (NASDAQ:AGIO - Free Report) by 8.0% in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 251,774 shares of thApril 28, 2025 | marketbeat.comAgios Pharmaceuticals (AGIO) to Release Quarterly Earnings on ThursdayAgios Pharmaceuticals (NASDAQ:AGIO) will be releasing its Q1 2025 earnings before the market opens on Thursday, May 1. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2025-5-1-agios-pharmaceuticals-inc-stock/)April 26, 2025 | marketbeat.comRock Springs Capital Management LP Cuts Holdings in Agios Pharmaceuticals, Inc. (NASDAQ:AGIO)Rock Springs Capital Management LP reduced its holdings in shares of Agios Pharmaceuticals, Inc. (NASDAQ:AGIO - Free Report) by 32.6% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owneApril 23, 2025 | marketbeat.comAgios Pharmaceuticals, Inc. (NASDAQ:AGIO) Shares Sold by Marshall Wace LLPMarshall Wace LLP trimmed its holdings in shares of Agios Pharmaceuticals, Inc. (NASDAQ:AGIO - Free Report) by 50.0% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 631,628 shares of the biopharmaceutical companyApril 22, 2025 | marketbeat.comAgios Pharmaceuticals price target lowered to $52 from $54 at BofAApril 18, 2025 | markets.businessinsider.comAgios to Webcast Conference Call of First Quarter Financial Results on May 1, 2025April 17, 2025 | globenewswire.comAgios Pharmaceuticals, Inc. (NASDAQ:AGIO) Given Average Recommendation of "Moderate Buy" by BrokeragesAgios Pharmaceuticals, Inc. (NASDAQ:AGIO - Get Free Report) has been assigned an average recommendation of "Moderate Buy" from the nine brokerages that are currently covering the firm, Marketbeat.com reports. Four investment analysts have rated the stock with a hold recommendation and five have givApril 16, 2025 | marketbeat.comKennedy Capital Management LLC Grows Stock Holdings in Agios Pharmaceuticals, Inc. (NASDAQ:AGIO)Kennedy Capital Management LLC grew its holdings in Agios Pharmaceuticals, Inc. (NASDAQ:AGIO - Free Report) by 281.4% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 111,098 shares of the biopharmaceutical comApril 15, 2025 | marketbeat.comAgios Pharmaceuticals, Inc. (NASDAQ:AGIO) Shares Sold by Martingale Asset Management L PMartingale Asset Management L P trimmed its holdings in shares of Agios Pharmaceuticals, Inc. (NASDAQ:AGIO - Free Report) by 56.0% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 15,520 shares of the biopharmaceutical companApril 15, 2025 | marketbeat.comFranklin Resources Inc. Purchases 30,144 Shares of Agios Pharmaceuticals, Inc. (NASDAQ:AGIO)Franklin Resources Inc. increased its position in Agios Pharmaceuticals, Inc. (NASDAQ:AGIO - Free Report) by 83.0% in the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 66,461 shares of the biopharmaceutical company's stock after buying an additional 30,144 sharesApril 15, 2025 | marketbeat.comEquities Analysts Offer Predictions for AGIO FY2025 EarningsAgios Pharmaceuticals, Inc. (NASDAQ:AGIO - Free Report) - Equities research analysts at Zacks Research cut their FY2025 earnings per share estimates for Agios Pharmaceuticals in a report released on Wednesday, April 9th. Zacks Research analyst A. Chakraborty now expects that the biopharmaceuticalApril 15, 2025 | marketbeat.comNorges Bank Purchases Shares of 145,092 Agios Pharmaceuticals, Inc. (NASDAQ:AGIO)Norges Bank purchased a new stake in shares of Agios Pharmaceuticals, Inc. (NASDAQ:AGIO - Free Report) in the 4th quarter, according to the company in its most recent disclosure with the SEC. The firm purchased 145,092 shares of the biopharmaceutical company's stock, valued at approximately $4,768,April 12, 2025 | marketbeat.comSei Investments Co. Sells 9,568 Shares of Agios Pharmaceuticals, Inc. (NASDAQ:AGIO)Sei Investments Co. decreased its position in Agios Pharmaceuticals, Inc. (NASDAQ:AGIO - Free Report) by 41.3% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 13,601 shares of the biopharmaceutical compaApril 12, 2025 | marketbeat.comAgios Pharmaceuticals, Inc. (NASDAQ:AGIO) Stake Lifted by CenterBook Partners LPCenterBook Partners LP raised its stake in Agios Pharmaceuticals, Inc. (NASDAQ:AGIO - Free Report) by 98.3% during the fourth quarter, according to its most recent disclosure with the SEC. The fund owned 305,599 shares of the biopharmaceutical company's stock after buying an additional 151,511 sharApril 11, 2025 | marketbeat.comAgios Pharmaceuticals, Inc. (NASDAQ:AGIO) Director Jacqualyn A. Fouse Sells 7,497 SharesApril 11, 2025 | insidertrades.comCapula Management Ltd Makes New Investment in Agios Pharmaceuticals, Inc. (NASDAQ:AGIO)Capula Management Ltd acquired a new stake in shares of Agios Pharmaceuticals, Inc. (NASDAQ:AGIO - Free Report) during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm acquired 20,849 shares of the biopharmaceutical compApril 10, 2025 | marketbeat.comTrexquant Investment LP Grows Position in Agios Pharmaceuticals, Inc. (NASDAQ:AGIO)Trexquant Investment LP grew its stake in Agios Pharmaceuticals, Inc. (NASDAQ:AGIO - Free Report) by 180.3% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 69,971 shares of the biophaApril 9, 2025 | marketbeat.comJPMorgan Chase & Co. Decreases Holdings in Agios Pharmaceuticals, Inc. (NASDAQ:AGIO)JPMorgan Chase & Co. reduced its position in Agios Pharmaceuticals, Inc. (NASDAQ:AGIO - Free Report) by 40.7% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 1,015,360 shares of the biopharmaceutical company's stock afApril 9, 2025 | marketbeat.comVanguard Group Inc. Boosts Stake in Agios Pharmaceuticals, Inc. (NASDAQ:AGIO)Vanguard Group Inc. raised its position in Agios Pharmaceuticals, Inc. (NASDAQ:AGIO - Free Report) by 1.5% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 5,631,321 shares of the biopharmaceutical companApril 8, 2025 | marketbeat.comMBX Biosciences Appoints Veteran Pharmaceutical Executive Steve Hoerter to Board of DirectorsApril 7, 2025 | finance.yahoo.comKLP Kapitalforvaltning AS Makes New $329,000 Investment in Agios Pharmaceuticals, Inc. (NASDAQ:AGIO)KLP Kapitalforvaltning AS bought a new stake in shares of Agios Pharmaceuticals, Inc. (NASDAQ:AGIO - Free Report) in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund bought 10,000 shares of the biopharmaceutical companyApril 7, 2025 | marketbeat.comAgios Pharmaceuticals (NASDAQ:AGIO) Sets New 1-Year Low - What's Next?Agios Pharmaceuticals (NASDAQ:AGIO) Hits New 1-Year Low - Should You Sell?April 6, 2025 | marketbeat.comHeadlands Technologies LLC Buys 12,989 Shares of Agios Pharmaceuticals, Inc. (NASDAQ:AGIO)Headlands Technologies LLC increased its stake in shares of Agios Pharmaceuticals, Inc. (NASDAQ:AGIO - Free Report) by 94.5% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 26,736 shares of the biopharmaceuticalApril 4, 2025 | marketbeat.comPictet Asset Management Holding SA Sells 46,394 Shares of Agios Pharmaceuticals, Inc. (NASDAQ:AGIO)Pictet Asset Management Holding SA lowered its position in Agios Pharmaceuticals, Inc. (NASDAQ:AGIO - Free Report) by 11.6% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 354,455 sharesApril 4, 2025 | marketbeat.comAgios Pharmaceuticals (NASDAQ:AGIO) Trading Down 4.4% - What's Next?Agios Pharmaceuticals (NASDAQ:AGIO) Trading Down 4.4% - Here's What HappenedApril 3, 2025 | marketbeat.comShort Interest in Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) Declines By 13.7%Agios Pharmaceuticals, Inc. (NASDAQ:AGIO - Get Free Report) was the target of a large decline in short interest in March. As of March 15th, there was short interest totalling 3,400,000 shares, a decline of 13.7% from the February 28th total of 3,940,000 shares. Based on an average daily trading volume, of 781,700 shares, the short-interest ratio is presently 4.3 days. Currently, 6.2% of the company's stock are sold short.April 3, 2025 | marketbeat.comPrudential Financial Inc. Boosts Stake in Agios Pharmaceuticals, Inc. (NASDAQ:AGIO)Prudential Financial Inc. lifted its stake in shares of Agios Pharmaceuticals, Inc. (NASDAQ:AGIO - Free Report) by 111.9% in the fourth quarter, according to its most recent filing with the SEC. The fund owned 104,922 shares of the biopharmaceutical company's stock after acquiring an additional 55,April 3, 2025 | marketbeat.comMOMA Therapeutics Appoints Susan Pandya, M.D., to Board of Directors and Expands Management TeamApril 1, 2025 | finance.yahoo.comLoomis Sayles & Co. L P Trims Stake in Agios Pharmaceuticals, Inc. (NASDAQ:AGIO)Loomis Sayles & Co. L P lowered its position in Agios Pharmaceuticals, Inc. (NASDAQ:AGIO - Free Report) by 31.9% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 417,208 shares of the biopharmaceutical company's stock after selling 195March 30, 2025 | marketbeat.com Get Agios Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for AGIO and its competitors with MarketBeat's FREE daily newsletter. Email Address AGIO Media Mentions By Week AGIO Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AGIO News Sentiment▼0.650.73▲Average Medical News Sentiment AGIO News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AGIO Articles This Week▼266▲AGIO Articles Average Week Get Agios Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for AGIO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies TG Therapeutics News Legend Biotech News Sarepta Therapeutics News Telix Pharmaceuticals Limited American Depositary Shares News ADMA Biologics News Blueprint Medicines News Verona Pharma News Nuvalent News Axsome Therapeutics News Grifols News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:AGIO) was last updated on 5/5/2025 by MarketBeat.com Staff From Our PartnersElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredElon Reveals Why There Soon Won’t Be Any Money For Social SecurityElon Musk's Near-Death Experience Sparks Dire Warning for Americans After cheating death twice—once in a te...Colonial Metals | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredTrump’s Bitcoin Reserve is No Accident…Bryce Paul believes this is the #1 coin to buy right now The catalyst behind this surge is a massive new b...Crypto 101 Media | SponsoredShocking AI play that’s beats Nvidia by a country mileYou’ve seen the headlines about Nvidia. Now Tim Sykes is sounding the alarm — because what CEO Jensen Huang is...Timothy Sykes | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredMan who predicted $100K Bitcoin sees a huge run coming for another coin …Sure enough, Bitcoin took off on the exact day Juan said it would. It's up more than 40% since the election...Weiss Ratings | SponsoredMusk's warning signal: Prepare before the cascade beginsWhen Elon Musk triggered his AI layoff plan, most analysts missed what it really meant. Louis Navellier didn’t...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Agios Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Agios Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy AGIO Stock Free AGIO Stock Alerts